Articles in support of Corsano’s scientific approach.

Corsano Health Winner at HIMSS! 

We are thrilled to announce that our CEO Peter Stas presented Corsano Health's innovative CardioWatch solution at HIMSS24 Startup Competition in Rome. This prestigious event showcases groundbreaking health tech and we are honored to be recognized among the best.

Corsano Health Receives FDA Clearance

Corsano Health is announcing that its CardioWatch 287-2 System received FDA Clearance.

Corsano Cuffless Non-Invasive Blood Pressure

Collaborating researchers from Reinier de Graaf Hospital have validated the Corsano cuffless photoplethysmography-based wristband for measuring blood pressure according to the regulatory standards.

Corsano CardioWatch Detects Cardiac Arrest

Collaborating researchers from Radboud University Medical Center, Erasmus MC, Reinier de Graaf Hospital, and Corsano Health have succeeded in reliably measuring whether a patient's circulation stops, as in the case of cardiac arrest.

Corsano at CiscoLive

Cisco and Corsano closely collaborated on the new Cisco Platform for In-Hospital Monitoring of patients. The revolutionary solution was showcased at Cisco Live 2024. The Corsano Bracelet streamed Vital Signs over BLE to Cisco’s latest router live at the Cisco Live event. We are proud to be Cisco’s Wearable Partner.

Cardiac Arrest Project Attracts Donations

Radboud University Medical Center (RadboudUMC) has initiated a donation campaign to support the DETECT Cardiac Arrest project. This vital initiative aims to enhance the detection and response strategies for cardiac arrests, potentially saving numerous lives.

Pharma Vigilance

Pharmacovigilance, often referred to as "pharma vigilance," involves the activities related to the detection, assessment, understanding, and prevention of drug-related adverse effects.

Corsano CardioWatch Detects Cardiac Arrest

Collaborating researchers from Radboud University Medical Center, Erasmus MC, Reinier de Graaf Hospital, and Corsano Health have succeeded in reliably measuring whether a patient's circulation stops, as in the case of cardiac arrest.

Educating the healthcare workforce of the future: lessons learned from the development and implementation o...

Students had Corsano CardioWatch 287-2 on their wrists, providing them with a practical opportunity to utilize medical-grade sensors. This allowed students to analyze their physiological responses throughout the course.

Sequential Validation of a Cuffless Photoplethysmography-Based Wristband for Blood Pressure Measurement

Hypertension increases cardiovascular risk. Measuring reliable blood pressure (sBP and dBP for systolic and diastolic BP) is challenging. A photoplethysmography (PPG)-based wristband with a custom BP algorithm could provide continuous BP.

The accuracy of heartbeat detection using photoplethysmography technology in cardiac patients

This validation study showed that the Corsano 287 CardioWatch/Bracelet with PPG-technology can determine HR and RR-intervals with high accuracy in a cardiovascular patient population

Smartphone and wearable detected atrial arrhythmias in Older Adults: Results of a fully digital European Ca...

The fully remote, investigator-initiated Smartphone and Corsano Health’s CardioWatch 287 wearable detected atrial arrhythmia in Older Adults Case finding study (Smart in OAC—AFNET 9) digitally enrolled participants ≥65 years without known atrial fibrillation

Validation of a novel cuffless photoplethysmography-based wristband for measuring blood pressure according ...

Chronic hypertension is a significant risk factor for cardiovascular diseases (CVD) [1]. However, obtaining reliable and reproducible cuff blood pressure (BP) measurements is challenging.

Automated cardiac arrest DETECTion based on wrist-derived PPG signals: preliminary results of the DETECT-1 ...

Automated cardiac arrest detection and alarming is a potential solution to shorten treatment delays after out-of-hospital cardiac arrest (OHCA). Especially for patients with unwitnessed cardiac arrests this could improve survival.

Determine atrial fibrillation burden with a photoplethysmographic mobile sensor: the atrial fibrillation bu...

Recent studies suggest that atrial fibrillation (AF) burden (time AF is present) is an independent risk factor for stroke. The aim of this trial was to study the feasibility and accuracy to identify AF episodes and quantify AF burden

Continuous respiration rate monitoring using photoplethysmography technology in patients with Obstructive S...

Respiration rate is an important physiological parameter whose abnormality has been regarded as an important indicator of various serious illnesses. Photoplethysmography (PPG) in wearable sensors potentially plays an important role in early disease detection by making respiration rate measurements

Validation Corsano Steps Algorithm (Abstract)

Comparison measured steps per minute determined by the Cardiowatch with steps per minute determined with the Actigraph CENTREPOINT Insight Watch. Single center prospective observational study collecting PPG and accelerometer data in a real world setting.

Analyzability of Photoplethysmographic Smartwatch Data During Everyday Life: Feasibility Study

A total of 41 (19 female and 22 male) adults in good cardiovascular health (aged 19-79 years) continuously wore a smartwatch equipped with a PPG sensor and a 3D accelerometer (Cardio Watch 287, Corsano Health BV) for a period of 24 hours that represented their individual daily routine.

Corsano Health Cardiowatch 287 USA Usability Study

Regulations and standards put the emphasis on usability and human factor design in the development of medical device and risk management. This paper explains the main challenges for wearable devices by showing how usability and human

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: S...

Screening for atrial fibrillation and timely initiation of oral anticoagulation, rhythm management, and treatment of concomitant cardiovascular conditions can improve outcomes in high-risk populations.

AF detection using Smartphone Apps

70 patients in an AF rhythm and 70 patients in sinus rhythm were recruited. Mean age was 73±12 (60% male) in the AF group, 59±20 in the sinus rhythm group (66% male). The BeatScanner app had a sensitivity of 89% (95% CI: 79-95%) and specificity of 67% (55- 78%).

Validation of Photoplethysmography-Based Sleep Staging Compared With Polysomnography

Corsano’s sleep analysis is powered by Philips Wearable Sensing algorithms. This clinical trial is using wrist-worn PPG to analyze heart rate variability and an accelerometer to measure body movements, sleep stages and sleep statistics were automatically computed from overnight recordings.

The Effectiveness of Utilizing HRV Indices as a Predictor of ACFT Performance Outcomes

The Army Combat Fitness Test (ACFT) is a performance assessment used by the U.S. Army to assess a cadet’s strength, endurance, and agility with a series of six events to ensure that cadets are combat ready.

The Corsano system for early Sepsis detection (CORSEP) trial.

The Corsano system for early Sepsis detection (CORSEP) trial. A collaborative trial between Universitätsmedizin Greifswald and Corsano Health B.V.

Accuracy of Respiratory Rate measurement by CardioWatch287-2 in patients (ACW2-PAT) 

RR will be obtained by FDA cleared Reference Device General Electric® Carescape B850 cleared under K131414 with an oxygen mask Oxymask OM-1125-8 with an anesthesia gas sampling line of 2 m.

Photoplethysmography to detect circulatory arrest: A study in patients with induced cardiac arrests

Out-of-hospital cardiac arrest (OHCA) is a leading cause of global mortality. Delays to initiation of cardiopulmonary resuscitation (CPR) should be as short as possible to achieve the highest survival chance.

RECAMO: REmote CArdiac MOnitoring by the Corsano Cardiowatch 287-2 of BP and AF

Wearables have the potential to monitor patients remotely. The Corsano CardioWatch 287-2 is such a medical device that can monitor atrial fibrillation and long-term blood pressure.

Multi Parameter Vital Signs Monitoring by the Corsano Cardiowatch 287-2 Validation Study

MULTI-VITAL Multi Parameter Vital Signs Monitoring by the Corsano Cardiowatch 287-2 Validation Study

The potential of a wearable monitoring bracelet for COPD patients

Investigating the potential of Corsano Cardiowatch 287 monitoring bracelet in monitoring patients with Chronic Obstructive Pulmonary Disease (COPD) at high risk of exacerbations

Phenotyping and Classifying Asthma Exacerbations (ExCluSie-F)

An observational study in patients between 12 and 70 years old with an acute asthma exacerbation, to determine the relation between phenotypical characteristics and the treatment response.

Validation Respiration Rate (BRPM) compared with Polygraphy

Evaluation of the performance and efficacy of the Corsano Cardiowatch 287 Bracelet in measuring respiratory rate at rest, as compared to golden standard and predicate device.

Safety and efficacy of anti-CD19 CAR T in subjects with Chronic Lymphocytic Leukemia or Small Lymphocytic L...

A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured 19CP02 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.

PPG AF-Burden Clinical Trial CCN-AMC

Evaluation of the performance of the Corsano Cardiowatch 287 Bracelet in identifying AF episodes and determining the AF burden in patients with known paroxysmal AF

Accuracy of CardioWatch 287-2 during profound hypoxia CMC

The present study is looking for calibration and accuracy of SpO2, Pulse Rate and Respiration Rate derived by a newly developed based wrist device (CardioWatch 287-2 or Test Device).

Population-based preconception intervention study for a healthy start of life

The first 1000 days of life reflect the period from the 3 months before conception until the age of 2 years. An accumulating body of evidence suggest that social-demographic background

Validation PPG measured HR and RR compared with ECG

To study the feasibility, efficacy and performance of the Corsano CardioWatch 287 module with a photoplethysmographic sensor for measuring heart rate and RR-intervals

Tele-TOKS: Implementation of an early warning system

Vital sign changes often precede cardiac arrest, unexpected death, or ICU admission. If observed and treated, it could prevent the patient’s condition from deteriorating.

Smart in OAC – AFNET 9

To demonstrate that patients with previously unknown atrial arrhythmias can be detected by a wearable in combination with Preventicus Heartbeats Core using a completely digital patient data capture system.

Atrial Fibrillation detection in OBESity using Ehealth

Obesity is a global epidemic. Obesity is associated with an increased risk of atrial fibrillation (AF). AF is the most common sustained cardiac rhythm disorder in humans with potentially life threatening complications.

SmartAF – Monitoring of Atrial Fibrillation in Hospitalized Patients for Stroke Prevention

Atrial fibrillation (AF) is the most common cardiac arrhythmia and a major risk factor for cerebrovascular insults. Screening for AF in hospitalized patients is challenging. The classical ECG monitoring requires

MINDfulness in Cardiac Obesity Rehabilitation using E-health (MINDCORE) – pilot study

The number of cardiac patients with obesity is rising, however their number of referral to cardiac rehabilitation (CR) is not. Patients with obesity report a higher level of anxiety, a greater fear of movement after a cardiac event

DivAirCity: Personal exposure to air pollution and associated vital signs

In this study, we try to investigate the impact of air quality and green-blue spaces on vital signs, stress, and mood states. Using a scripted exposure protocol subjects will perform aerobic exercises

Generation R Next: Longitudinal study that examines the growth, development, and health of children

The first 1000 days of life reflect the period from the 3 months before conception until the age of 2 years. An accumulating body of evidence suggest that social-demographic background, lifestyle and nutrition of both parents during

Determine AF Burden With PPG Trial – Detection and Quantification of Episodes of Atrial Fibrillation

In this prospective single-center trial, a wearable photoplethysmographic (PPG) sensor coupled with a cloud analytics service will be used to detect and quantify atrial fibrillation (AF) episodes in patients with known paroxysmal AF.

Corsano EndoWatch: The smart wearable that helps to improve life of patients after treatment of a suprasell...

Patients with a suprasellar (hypothalamic) brain tumour often have excellent survival, but poor outcome due to hypothalamic dysfunction (HD). The hypothalamus is an endocrine gland and the key-regulator of our body.

Realtime monitoring of activity and feedback for patients with femoral bone metastases

Bone metastases represent a common complication in cancer patients, particularly in advanced stages of the disease. The presence of bone metastases can cause skeletal-related events, such as bone pain, pathological fractures

Cuffless Non-Invasive Blood Pressure Research Presented at American Heart Association 2023 Scientific Sessions

Dr. Eelko Ronner PhD presented study findings from a collaboration with Reinier de Graaf Hospital that found Cuffless NIBP resulted in accurate prediction of blood pressure based on an AI Pulse Wave Analysis model.

Validation of a novel cuffless photoplethysmography-based wristband for measuring blood pressure according ...

August 28, 2023, the Research Team of Reinier de Graaf Hospital presented results of the Corsano Cuffless Non-Invasive Blood Pressure at the ESC in Amsterdam.

Corsano Health launches Cuffless Blood Pressure

Corsano Health is launching the company’s CardioWatch EU-MDR certified patient monitoring bracelet with Cuffless Non-Invasive Blood Pressure at ESC in Amsterdam…

Corsano & SepsisDialog won the 1st prize at healthcare hackathon

Sepsis is a life-threatening emergency. Under the leadership of Dr. Matthias Gründling, SepsisDialog has been working on the early detection and treatment of sepsis for about 30 years.

Corsano Health signs collaboration agreement with Roche Diagnostics enabling clinical insights in point-of-...

Corsano’s CardioWatch EU-MDR certified patient monitoring bracelet will connect to cobas® pulse, Roche’s digitally enabled professional blood glucose management solution, combining multiple health applications in one device.

Corsano Health CardioWatch 287-2 EU-MDR Certified

Corsano Health is launching the company’s second-generation EU-MDR wearable device that accurately measures eight vital parameters and makes raw PPG and ACC data available for further analysis by third party medical algorithm developers.

Parker Health x Corsano Health Partnership

Revolutionizing the use of patient centric data in correlating effective clinical outcomes.

Corsano Health in RTL News

This technology should save thousands of lives: recognise cardiac arrests and sound an alarm. Corsano Health CardioWatch in Radboudumc Cardiac Arrest Clinical Trial.

Corsano Health: Revolutionizing Continuous Remote Health Monitoring

As the benefits of remote patient monitoring (RPM) grow increasingly evident, wearable devices emerge as the revolutionary reformation of health assessment.

Smartwatch should save thousands of lives: recognize cardiac arrests and sound an alarm

Corsano Health CardioWatch in Radboudumc Cardiac Arrest Clinical Trial Every year, approximately 17,000 Dutch people suffer a cardiac arrest outside the hospital. 7000 to 8000 this happens without someone being there to alert the emergency services. Radboudumc in Nijmegen and Corsano Health are now working on a special smartwatch.

Corsano Health Receives EU-MDR Certification

Notified Body DARE!! Services B.V. declares that it has audited the quality assurance system in accordance with MDR Annex IX and that the relevant provisions of the Regulation 2017/745 dated May 5, 2017 concerning Medical Devices are fulfilled.

Medical Certification

We are happy to announce that Corsano Health B.V. is medically certified complying with Annex IX (MDR) and EN-ISO 13485 standards.

PPG Accuracy

The accuracy of Corsano CardioWatch 287 with pulse detection using photoplethysmography technology in cardiac patients was studied by S. Blok [1,2], M.A. Piek [1], I.I. Tulevski [1], G.A. Somsen [1], M.M. Winter [1,3]. In this single-centre prospective study, patients from an outpatient cardiology clinic underwent a simultaneous resting ECG and PPG recording.

Cuffless Non-Invasive Blood Pressure

High blood pressure (hypertension) is a common condition in which the long-term force of the blood against the artery walls is high enough that it will eventually cause heart disease with a patient population of 300m+ across the EU and US. Long-term high blood pressure is a major risk factor for stroke, coronary artery disease, heart...

Sepsis Detection

Sepsis is a life-threatening condition characterized by a dysregulated immune response to infection, leading to organ dysfunction. It is considered a global health concern and a leading cause of death worldwide. Early detection and timely treatment are crucial for improving patient outcomes.

Atrial Fibrillation and Stroke

The most common cardiac arrhythmia is atrial fibrillation (AF). One in four will get it in the course of their life, the probability increases especially from the age of 65, as well as from 55 years with the presence of other risk factors (e.g. high blood pressure, diabetes, previous cardiovascular events) [1].

Cardiac Telemetry

Telemetry rhythm surveillance is standard of care for a large subgroup of hospitalized cardiac patients. Indications for telemetry vary throughout spectra of risks, from direct detection of a life threatening arrhythmia, to determination of a rhythm or conduction disorder, to observation of heart frequency when tailoring treatment.

Certified Software

Corsano has medically certified it’s new software platform under ISO 13485 and EU-MDR. Latest technologies have been applied and the Software Development Process has been meticulously documented for CE-MDR and FDA Certification.

Corsano CardioWatch Impact Framework

The ABPM scenario focuses on the impact of using one medical bracelet instead of the ABPM system, in the United States and Europe.

Innovative Horizons in Hypertension Monitoring: Corsano’s CardioWatch 287-2 System

Corsano’s CardioWatch 287-2 is a transformative solution for hypertension monitoring, highlighting its potential to replace traditional 24-hour ABPM.

Cardiac Surveillance in the Digital Age

Atrial arrhythmias in older adults present significant healthcare challenges. This paper evaluates the efficacy of Corsano CardioWatch, a remote patient monitoring (RPM) tool, in detecting atrial fibrillation.

Corsano Health Wins Call Heart Foundation

We are proud to announce that the Dutch Heart Foundation awarded Corsano Health a development project to recognize cardiac arrest and alert emergency services. Survival of Out-of-Hospital Cardiac Arrest (OHCA) depends on early recognition of Cardiac Arrest and initiation of Cardiopulmonary Resuscitation (CPR).